GREENPRO CAPITAL CORP (GRNQ)

US39540F3091 - Common Stock

1.05  -0.22 (-17.32%)

After market: 0.98 -0.07 (-6.67%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GRNQ. GRNQ was compared to 222 industry peers in the Capital Markets industry. Both the profitability and financial health of GRNQ have multiple concerns. GRNQ is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

GRNQ had negative earnings in the past year.
GRNQ had a negative operating cash flow in the past year.
GRNQ had negative earnings in 4 of the past 5 years.
GRNQ had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

GRNQ has a worse Return On Assets (-98.96%) than 99.08% of its industry peers.
Looking at the Return On Equity, with a value of -138.06%, GRNQ is doing worse than 95.85% of the companies in the same industry.
Industry RankSector Rank
ROA -98.96%
ROE -138.06%
ROIC N/A
ROA(3y)-30.46%
ROA(5y)-26.38%
ROE(3y)-36.77%
ROE(5y)-39.7%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GRNQ has a better Gross Margin (83.96%) than 86.64% of its industry peers.
In the last couple of years the Gross Margin of GRNQ has grown nicely.
The Profit Margin and Operating Margin are not available for GRNQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y10.56%

3

2. Health

2.1 Basic Checks

The number of shares outstanding for GRNQ has been reduced compared to 1 year ago.
The number of shares outstanding for GRNQ has been increased compared to 5 years ago.
GRNQ has a worse debt/assets ratio than last year.

2.2 Solvency

GRNQ has an Altman-Z score of -5.93. This is a bad value and indicates that GRNQ is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of GRNQ (-5.93) is worse than 94.01% of its industry peers.
GRNQ has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, GRNQ belongs to the top of the industry, outperforming 88.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.93
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.35 indicates that GRNQ should not have too much problems paying its short term obligations.
With a Current ratio value of 1.35, GRNQ perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
A Quick Ratio of 1.35 indicates that GRNQ should not have too much problems paying its short term obligations.
GRNQ's Quick ratio of 1.35 is in line compared to the rest of the industry. GRNQ outperforms 58.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35

0

3. Growth

3.1 Past

GRNQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -354.59%.
Looking at the last year, GRNQ shows a very negative growth in Revenue. The Revenue has decreased by -17.10% in the last year.
Measured over the past years, GRNQ shows a decrease in Revenue. The Revenue has been decreasing by -3.75% on average per year.
EPS 1Y (TTM)-354.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118%
Revenue 1Y (TTM)-17.1%
Revenue growth 3Y15.62%
Revenue growth 5Y-3.75%
Sales Q2Q%-49.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRNQ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GRNQ!.
Industry RankSector Rank
Dividend Yield N/A

GREENPRO CAPITAL CORP

NASDAQ:GRNQ (1/14/2025, 8:00:01 PM)

After market: 0.98 -0.07 (-6.67%)

1.05

-0.22 (-17.32%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners1.16%
Inst Owner Change0%
Ins Owners22.58%
Ins Owner Change0%
Market Cap7.96M
Analysts43.33
Price TargetN/A
Short Float %0.27%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.92
P/FCF N/A
P/OCF N/A
P/B 1.65
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)-0.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.36
BVpS0.64
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -98.96%
ROE -138.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.96%
FCFM N/A
ROA(3y)-30.46%
ROA(5y)-26.38%
ROE(3y)-36.77%
ROE(5y)-39.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y10.56%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.11%
Cap/Sales 3.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z -5.93
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)26.98%
Cap/Depr(5y)16.93%
Cap/Sales(3y)1.27%
Cap/Sales(5y)0.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-354.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.1%
Revenue growth 3Y15.62%
Revenue growth 5Y-3.75%
Sales Q2Q%-49.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.03%
OCF growth 3YN/A
OCF growth 5YN/A